Events Category: Conferences

Participants including clinicians, researchers, FDA and global health authorities, industry partners, patients, and the Amyloidosis Research Consortium (ARC) will detail and highlight the advancements cultivated by Amyloidosis Forum working groups and outline goals and touchstones for future programs and research. This meeting is open to the public, with discussion intended for researchers, clinicians, regulators, patient representatives, and industry.